Amundi Intra Cellular Therapies, Inc. Transaction History
Amundi
- $275 Billion
- Q1 2025
A detailed history of Amundi transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, Amundi holds 561,266 shares of ITCI stock, worth $74 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
561,266
Previous 2,729
20466.73%
Holding current value
$74 Million
Previous $227,000
32517.62%
% of portfolio
0.03%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding ITCI
# of Institutions
449Shares Held
93.4MCall Options Held
2.24MPut Options Held
1.86M-
Vanguard Group Inc Valley Forge, PA9.52MShares$1.26 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY6.32MShares$834 Million0.01% of portfolio
-
Pentwater Capital Management LP Naples, FL5.19MShares$684 Million5.83% of portfolio
-
Davidson Kempner Capital Management LP New York, NY3.49MShares$460 Million16.46% of portfolio
-
Ubs Oconnor LLC Chicago, IL3.09MShares$408 Million28.36% of portfolio
About Intra-Cellular Therapies, Inc.
- Ticker ITCI
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 94,401,696
- Market Cap $12.4B
- Description
- Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...